Endocrine Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114.
Endocrine Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114; Pediatric Endocrinology, Marmara University School of Medicine Hospital, 34662 Istanbul, Turkey.
J Biol Chem. 2011 Nov 4;286(44):38558-38569. doi: 10.1074/jbc.M111.240150. Epub 2011 Sep 2.
Murine models indicate that Gαs and its extra-long variant XLαs, both of which are derived from GNAS, markedly differ regarding their cellular actions, but these differences are unknown. Here we investigated activation-induced trafficking of Gαs and XLαs, using immunofluorescence microscopy, cell fractionation, and total internal reflection fluorescence microscopy. In transfected cells, XLαs remained localized to the plasma membrane, whereas Gαs redistributed to the cytosol after activation by GTPase-inhibiting mutations, cholera toxin treatment, or G protein-coupled receptor agonists (isoproterenol or parathyroid hormone (PTH)(1-34)). Cholera toxin treatment or agonist (isoproterenol or pituitary adenylate cyclase activating peptide-27) stimulation of PC12 cells expressing Gαs and XLαs endogenously led to an increased abundance of Gαs, but not XLαs, in the soluble fraction. Mutational analyses revealed two conserved cysteines and the highly charged domain as being critically involved in the plasma membrane anchoring of XLαs. The cAMP response induced by M-PTH(1-14), a parathyroid hormone analog, terminated quickly in HEK293 cells stably expressing the type 1 PTH/PTH-related peptide receptor, whereas the response remained maximal for at least 6 min in cells that co-expressed the PTH receptor and XLαs. Although isoproterenol-induced cAMP response was not prolonged by XLαs expression, a GTPase-deficient XLαs mutant found in certain tumors and patients with fibrous dysplasia of bone and McCune-Albright syndrome generated more basal cAMP accumulation in HEK293 cells and caused more severe impairment of osteoblastic differentiation of MC3T3-E1 cells than the cognate Gαs mutant (gsp oncogene). Thus, activated XLαs and Gαs traffic differently, and this may form the basis for the differences in their cellular actions.
鼠模型表明,Gαs 和其超长变体 XLαs 均源自 GNAS,在细胞作用方面有明显差异,但这些差异尚不清楚。在这里,我们使用免疫荧光显微镜、细胞分级分离和全内反射荧光显微镜研究了 Gαs 和 XLαs 的激活诱导的转运。在转染细胞中,XLαs 仍然定位于质膜,而 Gαs 在被 GTPase 抑制突变、霍乱毒素处理或 G 蛋白偶联受体激动剂(异丙肾上腺素或甲状旁腺激素(1-34))激活后重新分布到细胞质中。用霍乱毒素处理或激动剂(异丙肾上腺素或垂体腺苷酸环化酶激活肽-27)刺激表达 Gαs 和 XLαs 的 PC12 细胞,导致可溶性部分中 Gαs 的含量增加,但 XLαs 的含量没有增加。突变分析表明,两个保守的半胱氨酸和带正电荷的结构域对于 XLαs 的质膜锚定至关重要。M-PTH(1-14),一种甲状旁腺激素类似物,在稳定表达 1 型甲状旁腺激素/甲状旁腺激素相关肽受体的 HEK293 细胞中诱导的 cAMP 反应迅速终止,而在共表达甲状旁腺激素受体和 XLαs 的细胞中,该反应至少持续 6 分钟保持最大。虽然 XLαs 的表达没有延长异丙肾上腺素诱导的 cAMP 反应,但在某些肿瘤和纤维结构不良性骨疾病和 McCune-Albright 综合征患者中发现的具有 GTPase 缺陷的 XLαs 突变体在 HEK293 细胞中产生更多的基础 cAMP 积累,并导致 MC3T3-E1 细胞的成骨分化受到更严重的损害比同源 Gαs 突变体(gsp 致癌基因)。因此,激活的 XLαs 和 Gαs 的转运方式不同,这可能是它们细胞作用差异的基础。